Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS.


Journal

Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388

Informations de publication

Date de publication:
04 05 2020
Historique:
received: 11 07 2019
accepted: 07 01 2020
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 3 8 2021
Statut: epublish

Résumé

We applied longitudinal 3T MRI and advanced computational models in 2 independent cohorts of patients with early MS to investigate how white matter (WM) lesion distribution and cortical atrophy topographically interrelate and affect functional disability. Clinical disability was measured using the Expanded Disability Status Scale Score at baseline and at 1-year follow-up in a cohort of 119 patients with early relapsing-remitting MS and in a replication cohort of 81 patients. Covarying patterns of cortical atrophy and baseline lesion distribution were extracted by parallel independent component analysis. Predictive power of covarying patterns for disability progression was tested by receiver operating characteristic analysis at the group level and support vector machine for individual patient outcome. In the study cohort, we identified 3 distinct distribution types of WM lesions (cerebellar, bihemispheric, and left lateralized) that were associated with characteristic cortical atrophy distributions. The cerebellar and left-lateralized patterns were reproducibly detected in the second cohort. Each of the patterns predicted to different extents, short-term disability progression, whereas the cerebellar pattern was associated with the highest risk of clinical worsening, predicting individual disability progression with an accuracy of 88% (study cohort) and 89% (replication cohort), respectively. These findings highlight the role of distinct spatial distribution of cortical atrophy and WM lesions predicting disability. The cerebellar involvement is shown as a key determinant of rapid clinical deterioration.

Identifiants

pubmed: 32024782
pii: 7/3/e681
doi: 10.1212/NXI.0000000000000681
pmc: PMC7051213
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Références

Ann Neurol. 1994;36 Suppl:S108-12
pubmed: 8017868
Trends Neurosci. 2010 Apr;33(4):202-10
pubmed: 20153532
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Neuroscience. 2019 Apr 1;403:35-53
pubmed: 29101079
Brain Pathol. 2015 Nov;25(6):692-700
pubmed: 25411024
Mult Scler. 2017 May;23(6):848-854
pubmed: 27527906
Hum Brain Mapp. 2006 Jan;27(1):47-62
pubmed: 16108017
J Neurophysiol. 2011 Nov;106(5):2322-45
pubmed: 21795627
Ann Neurol. 2008 Sep;64(3):247-54
pubmed: 18570297
Brain. 2016 Jan;139(Pt 1):115-26
pubmed: 26637488
Hum Brain Mapp. 2009 Jan;30(1):241-55
pubmed: 18072279
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Neurology. 2001 May 22;56(10):1324-30
pubmed: 11376182
J Neurol. 2008 Sep;255(9):1378-83
pubmed: 18584233
JAMA Neurol. 2013 Dec;70(12):1569-74
pubmed: 24145957
Front Neurosci. 2016 Feb 02;10:14
pubmed: 26869873
J Neurol. 2007 Sep;254(9):1212-20
pubmed: 17361339
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Brain. 2019 Jan 1;143(1):150-160
pubmed: 31730165
Neuroimage Clin. 2016 Oct 12;12:806-814
pubmed: 27830113
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6356-E6365
pubmed: 29925602
Mult Scler. 2017 Mar;23(3):432-441
pubmed: 27246143
Mult Scler Relat Disord. 2016 Jul;8:99-106
pubmed: 27456883
Mult Scler. 2011 Sep;17(9):1079-87
pubmed: 21511688
Hum Brain Mapp. 2007 Nov;28(11):1251-66
pubmed: 17274023
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):219-226
pubmed: 30467210
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1109-15
pubmed: 24554101
Neuroimage Clin. 2016 Jun 14;12:123-31
pubmed: 27408797
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Ann Neurol. 2008 Sep;64(3):255-65
pubmed: 18661561
Front Hum Neurosci. 2015 Mar 03;9:100
pubmed: 25784871
Hum Brain Mapp. 2013 Nov;34(11):3000-9
pubmed: 22807270
J Neurol Sci. 2009 Jul 15;282(1-2):5-11
pubmed: 19201002
Arch Neurol. 2004 Feb;61(2):217-21
pubmed: 14967769
Neurology. 2013 Nov 12;81(20):1759-67
pubmed: 24122185
Neural Netw. 2003 Nov;16(9):1311-23
pubmed: 14622887
Neuroimage. 2010 Dec;53(4):1181-96
pubmed: 20637289
Mult Scler. 2017 Jun;23(7):973-981
pubmed: 27698248
Front Neurol. 2018 Oct 11;9:824
pubmed: 30364223
Neuroimage Clin. 2017 Nov 05;17:444-451
pubmed: 29159057
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1082-91
pubmed: 23524331

Auteurs

Muthuraman Muthuraman (M)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Vinzenz Fleischer (V)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Julia Kroth (J)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Dumitru Ciolac (D)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Angela Radetz (A)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Nabin Koirala (N)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Gabriel Gonzalez-Escamilla (G)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Heinz Wiendl (H)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Sven G Meuth (SG)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Frauke Zipp (F)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany.

Sergiu Groppa (S)

From the Department of Neurology (M.M., V.F., J.K., D.C., A.R., N.K., G.G.-E., F.Z., S.G.), Focus Program Translational Neuroscience (FTN), Research Center for Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn), University Medical Center of the Johannes Gutenberg University Mainz; and Department of Neurology with Institute of Translational Neurology (H.W., S.G.M.), University of Munster, Germany. segroppa@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH